Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Cytotoxicity of Prymnesium parvum extracts and prymnesin analogs on epithelial fish gill cells RTgill-W1 and the human colon cell line HCEC-1CT.
Varga E, Prause HC, Riepl M, Hochmayr N, Berk D, Attakpah E, Kiss E, Medić N, Del Favero G, Larsen TO, Hansen PJ, Marko D. Varga E, et al. Among authors: medic n. Arch Toxicol. 2024 Apr 9. doi: 10.1007/s00204-024-03716-3. Online ahead of print. Arch Toxicol. 2024. PMID: 38592475 No abstract available.
A dataset on trophic modes of aquatic protists.
Schneider LK, Anestis K, Mansour J, Anschütz AA, Gypens N, Hansen PJ, John U, Klemm K, Martin JL, Medic N, Not F, Stolte W. Schneider LK, et al. Among authors: medic n. Biodivers Data J. 2020 Oct 23;8:e56648. doi: 10.3897/BDJ.8.e56648. eCollection 2020. Biodivers Data J. 2020. PMID: 33177947 Free PMC article.
Mixoplankton interferences in dilution grazing experiments.
Duarte Ferreira G, Romano F, Medić N, Pitta P, Hansen PJ, Flynn KJ, Mitra A, Calbet A. Duarte Ferreira G, et al. Among authors: medic n. Sci Rep. 2021 Dec 13;11(1):23849. doi: 10.1038/s41598-021-03176-0. Sci Rep. 2021. PMID: 34903787 Free PMC article.
Patient-reported outcomes with durvalumab, with or without tremelimumab, plus chemotherapy as first-line treatment for metastatic non-small-cell lung cancer (POSEIDON).
Garon EB, Cho BC, Luft A, Alatorre-Alexander J, Geater SL, Kim SW, Ursol G, Hussein M, Lim FL, Yang CT, Araujo LH, Saito H, Reinmuth N, Medic N, Mann H, Shi X, Peters S, Mok T, Johnson M. Garon EB, et al. Among authors: medic n. Lung Cancer. 2023 Dec;186:107422. doi: 10.1016/j.lungcan.2023.107422. Epub 2023 Nov 11. Lung Cancer. 2023. PMID: 37992595 Free article. Clinical Trial.
Cyanidin 3-glucoside targets a hepatic bilirubin transporter in rats.
Pelizzo P, Stebel M, Medic N, Sist P, Vanzo A, Anesi A, Vrhovsek U, Tramer F, Passamonti S. Pelizzo P, et al. Among authors: medic n. Biomed Pharmacother. 2023 Jan;157:114044. doi: 10.1016/j.biopha.2022.114044. Epub 2022 Dec 1. Biomed Pharmacother. 2023. PMID: 36463829 Free article.
50 results